Skip to main page content
Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

MyNCBI Filters
Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1887 1
1940 1
1942 1
1946 1
1947 3
1949 2
1951 2
1952 2
1954 2
1956 3
1958 1
1960 2
1961 2
1962 3
1963 5
1964 1
1965 2
1967 1
1968 5
1969 4
1970 5
1971 12
1972 12
1973 8
1974 9
1975 8
1976 4
1977 7
1978 13
1979 12
1980 11
1981 11
1982 16
1983 12
1984 9
1985 13
1986 16
1987 24
1988 22
1989 19
1990 28
1991 29
1992 32
1993 31
1994 34
1995 50
1996 46
1997 19
1998 38
1999 38
2000 54
2001 34
2002 46
2003 51
2004 40
2005 44
2006 44
2007 60
2008 62
2009 90
2010 90
2011 82
2012 90
2013 90
2014 96
2015 102
2016 113
2017 118
2018 140
2019 110
2020 43
Text availability
Article attribute
Article type
Publication date

Search Results

2,053 results
Results by year
Filters applied: . Clear all
Page 1
Pre-Clinical Development of a Humanized Anti-CD47 Antibody with Anti-Cancer Therapeutic Potential.
Liu J, Wang L, Zhao F, Tseng S, Narayanan C, Shura L, Willingham S, Howard M, Prohaska S, Volkmer J, Chao M, Weissman IL, Majeti R. Liu J, et al. Among authors: Howard M. PLoS One. 2015 Sep 21;10(9):e0137345. doi: 10.1371/journal.pone.0137345. eCollection 2015. PLoS One. 2015. PMID: 26390038 Free PMC article.
Outcomes That Define Successful Advance Care Planning: A Delphi Panel Consensus.
Sudore RL, Heyland DK, Lum HD, Rietjens JAC, Korfage IJ, Ritchie CS, Hanson LC, Meier DE, Pantilat SZ, Lorenz K, Howard M, Green MJ, Simon JE, Feuz MA, You JJ. Sudore RL, et al. Among authors: Howard M. J Pain Symptom Manage. 2018 Feb;55(2):245-255.e8. doi: 10.1016/j.jpainsymman.2017.08.025. Epub 2017 Sep 1. J Pain Symptom Manage. 2018. PMID: 28865870 Free PMC article.
O2⋅- and H2O2-Mediated Disruption of Fe Metabolism Causes the Differential Susceptibility of NSCLC and GBM Cancer Cells to Pharmacological Ascorbate.
Schoenfeld JD, Sibenaller ZA, Mapuskar KA, Wagner BA, Cramer-Morales KL, Furqan M, Sandhu S, Carlisle TL, Smith MC, Abu Hejleh T, Berg DJ, Zhang J, Keech J, Parekh KR, Bhatia S, Monga V, Bodeker KL, Ahmann L, Vollstedt S, Brown H, Shanahan Kauffman EP, Schall ME, Hohl RJ, Clamon GH, Greenlee JD, Howard MA, Schultz MK, Smith BJ, Riley DP, Domann FE, Cullen JJ, Buettner GR, Buatti JM, Spitz DR, Allen BG. Schoenfeld JD, et al. Among authors: Howard MA. Cancer Cell. 2017 Apr 10;31(4):487-500.e8. doi: 10.1016/j.ccell.2017.02.018. Epub 2017 Mar 30. Cancer Cell. 2017. PMID: 28366679 Free PMC article. Clinical Trial.
Notalgia paresthetica: a review for dermatologists.
Howard M, Sahhar L, Andrews F, Bergman R, Gin D. Howard M, et al. Int J Dermatol. 2018 Apr;57(4):388-392. doi: 10.1111/ijd.13853. Epub 2017 Dec 15. Int J Dermatol. 2018. PMID: 29243804 Review.
First-in-Human, First-in-Class Phase I Trial of the Anti-CD47 Antibody Hu5F9-G4 in Patients With Advanced Cancers.
Sikic BI, Lakhani N, Patnaik A, Shah SA, Chandana SR, Rasco D, Colevas AD, O'Rourke T, Narayanan S, Papadopoulos K, Fisher GA, Villalobos V, Prohaska SS, Howard M, Beeram M, Chao MP, Agoram B, Chen JY, Huang J, Axt M, Liu J, Volkmer JP, Majeti R, Weissman IL, Takimoto CH, Supan D, Wakelee HA, Aoki R, Pegram MD, Padda SK. Sikic BI, et al. Among authors: Howard M. J Clin Oncol. 2019 Apr 20;37(12):946-953. doi: 10.1200/JCO.18.02018. Epub 2019 Feb 27. J Clin Oncol. 2019. PMID: 30811285 Clinical Trial.
Direct Oral Anticoagulants in Chronic Liver Disease.
Steuber TD, Howard ML, Nisly SA. Steuber TD, et al. Among authors: Howard ML. Ann Pharmacother. 2019 Oct;53(10):1042-1049. doi: 10.1177/1060028019841582. Epub 2019 Apr 4. Ann Pharmacother. 2019. PMID: 30947523
Direct Oral Anticoagulants in Cardioversion: A Review of Current Evidence.
Gibson CM, Basto AN, Howard ML. Gibson CM, et al. Among authors: Howard ML. Ann Pharmacother. 2018 Mar;52(3):277-284. doi: 10.1177/1060028017737095. Epub 2017 Oct 12. Ann Pharmacother. 2018. PMID: 29025267 Review.
2,053 results
Jump to page
Feedback